Fortress Biotech, Inc. (FBIO)
1.875
-0.12
(-5.78%)
USD |
NASDAQ |
Nov 13, 16:00
1.875
0.00 (0.00%)
After-Hours: 19:59
Fortress Biotech Price to Book Value : 0.3806 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 0.4039 |
| November 11, 2026 | 0.4079 |
| November 10, 2026 | 0.3876 |
| November 09, 2026 | 0.4039 |
| November 06, 2026 | 0.3755 |
| November 05, 2026 | 0.3734 |
| November 04, 2026 | 0.3998 |
| November 03, 2026 | 0.3937 |
| November 02, 2026 | 0.3917 |
| October 30, 2026 | 0.3897 |
| October 29, 2026 | 0.4059 |
| October 28, 2026 | 0.3978 |
| October 27, 2026 | 0.3917 |
| October 26, 2026 | 0.3795 |
| October 23, 2026 | 0.3917 |
| October 22, 2026 | 0.4039 |
| October 21, 2026 | 0.3937 |
| October 20, 2026 | 0.3937 |
| October 19, 2026 | 0.3795 |
| October 16, 2026 | 0.3795 |
| October 15, 2026 | 0.3876 |
| October 14, 2026 | 0.3856 |
| October 13, 2026 | 0.3957 |
| October 12, 2026 | 0.4282 |
| October 09, 2026 | 0.4333 |
| Date | Value |
|---|---|
| October 08, 2026 | 0.4242 |
| October 07, 2026 | 0.414 |
| October 06, 2026 | 0.416 |
| October 05, 2026 | 0.4242 |
| October 02, 2026 | 0.412 |
| October 01, 2026 | 0.4201 |
| September 30, 2026 | 0.4343 |
| September 29, 2026 | 0.4465 |
| September 28, 2026 | 0.4404 |
| September 25, 2026 | 0.4627 |
| September 24, 2026 | 0.4627 |
| September 23, 2026 | 0.4749 |
| September 22, 2026 | 0.4972 |
| September 21, 2026 | 0.4891 |
| September 18, 2026 | 0.5094 |
| September 17, 2026 | 0.5094 |
| September 16, 2026 | 0.4992 |
| September 15, 2026 | 0.5053 |
| September 14, 2026 | 0.5135 |
| September 11, 2026 | 0.5114 |
| September 10, 2026 | 0.5216 |
| September 09, 2026 | 0.5337 |
| September 08, 2026 | 0.55 |
| September 04, 2026 | 0.552 |
| September 03, 2026 | 0.55 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 14.48 |
| Nektar Therapeutics | 1.408 |
| DiaMedica Therapeutics, Inc. | 12.36 |
| Journey Medical Corp. | 3.686 |
| ACADIA Pharmaceuticals, Inc. | 2.334 |
Price to Book Value Related Metrics
| PE Ratio | 0.7058 |
| PS Ratio | 0.9220 |
| Price to Free Cash Flow | 0.5248 |
| Price | 1.875 |
| Earnings Yield | 141.7% |
| Market Cap | 62.46M |
| Normalized PE Ratio | 0.7657 |